Xconomy National

Archives

by in

Entry	Author	Date	Location
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy	Luke Timmerman	09/08/11	San Francisco
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients	Luke Timmerman	11/09/10	San Diego
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior	Ryan McBride	09/20/10	Boston
It’s Time for Universities to Get More Nimble	Regis Kelly	09/02/10	San Francisco
Logical Therapeutics Snags $10M to Make Pain Relievers Safer on the Gut	Luke Timmerman	05/21/10	Boston
Alder’s Long-Awaited Arthritis Data, Ikaria Plots $200M IPO, Emerald’s Resurrection, & More Seattle-Area Life Sciences News	Luke Timmerman	05/20/10	Seattle
Roche, Biogen Halt Arthritis Study	Luke Timmerman	03/08/10	Boston
Genomic Advances of the 2000s Will Demand an Informatics Revolution in the 2010s	Eric Schadt	01/14/10	National
It’s About Health Care, Not Health Insurance	Norm Wu	09/28/09	Seattle
ConforMIS Shapes Corporate Expansion with $50M D Round	Ryan McBride	07/13/09	Boston
KaloBios Gets $12M Genzyme, Baxter	Luke Timmerman	12/22/08	Boston
Alder Gets Early Christmas Present: FDA Slaps Down Its Rival, Roche	Luke Timmerman	12/08/08	Seattle
Korean Biotech Opens Mass. Office	Ryan McBride	12/04/08	Boston
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month	Luke Timmerman	11/20/08	Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says	Luke Timmerman	11/13/08	Boston
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure	Luke Timmerman	11/04/08	Boston
Trubion Shares Leap, Drop, Leap Again After Encouraging Clinical Trial News	Luke Timmerman	10/27/08	Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk	Luke Timmerman	10/27/08	Seattle
ZymoGenetics Gets $21M From Bristol-Myers To Settle Patent Suit	Luke Timmerman	10/23/08	Seattle
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial	Luke Timmerman	10/06/08	Boston
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way	Luke Timmerman	09/30/08	Boston
Ariad Loses Patent Case Against Amgen	Luke Timmerman	09/22/08	Boston
Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy	Luke Timmerman	09/18/08	Seattle
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors	Luke Timmerman	08/26/08	Seattle
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Page 1 of 1